Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in SMMT — Summit Therapeutics Inc.

CIK 1446194 BALA CYNWYD, PA
Back to SMMT Full portfolio

Position in SMMT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,595,909
-$3,854,660 QoQ
Shares Held
521,339
-13.7% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#37
of 242 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SMMT Over Time

Shares Held

Position Value (USD)

Derivatives in SMMT

reported options exposure · as of Jun 30, 2026
CallValue
$11,226,185
CallShares
770,500
PutValue
$16,161,044
PutShares
1,109,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. SMMT ranks #33 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in SMMT

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,595,909 521,339
2026-06-30 $11,226,185 770,500
2026-06-30 $16,161,044 1,109,200
2026-03-31 $11,450,569 603,933
2026-03-31 $23,497,128 1,239,300
2026-03-31 $10,759,800 567,500
2025-12-31 $25,593,117 1,463,300
2025-12-31 $31,529,223 1,802,700
2025-09-30 $5,093,970 246,562
2025-09-30 $25,174,210 1,218,500
2025-09-30 $28,752,522 1,391,700
2025-06-30 $22,965,376 1,079,200
2025-06-30 $22,265,264 1,046,300
2025-06-30 $6,383,425 299,973
2025-03-31 $11,087,892 574,800
2025-03-31 $14,469,429 750,100
2025-03-31 $4,889,995 253,499
2024-12-31 $7,014,869 393,100
2024-12-31 $5,474,846 306,800
2024-12-31 $1,378,062 77,224
2024-09-30 $13,383,090 611,100
2024-09-30 $8,024,050 366,395
2024-09-30 $10,625,880 485,200
2024-06-30 $1,061,580 136,100
2024-06-30 $1,979,647 253,801
2024-06-30 $2,559,960 328,200
2024-03-31 $667,938 161,338
2024-03-31 $329,130 79,500
2024-03-31 $88,182 21,300
2023-12-31 $122,931 47,100
2023-12-31 $601,213 230,350
2023-09-30 $24,871 13,300
2023-09-30 $1,088,714 582,200
2023-09-30 $236,313 126,371
2023-06-30 $952,147 379,342
2023-06-30 $35,893 14,300
2023-06-30 $151,353 60,300
2023-03-31 $283,500 162,000
2023-03-31 $2,954,988 1,688,565
2023-03-31 $392,700 224,400
2022-12-31 $1,191,802 280,424
2022-12-31 $2,897,650 681,800
2022-12-31 $2,417,825 568,900
2022-09-30 $97,231 81,707
2022-06-30 $23,637 23,637
2021-12-31 $38,900 14,461
2021-12-31 $65,367 24,300
2021-09-30 $64,228 12,820
2021-09-30 $337,674 67,400
2021-06-30 $800,458 107,300